diaendoСахарный диабетDiabetes mellitus2072-03512072-0378Endocrinology research centre10.14341/2072-0351-6218diaendo-6218Research ArticleСтатьиArticlesМембраноатакующий комплекс как показатель гиперактивации комплемента при сахарном диабете 2 типаThe membrane attack complex as an indicator of complement hyperactivation in type 2 diabetes mellitusАракеловаЭлина АлександровнаArakelovaElina Alexandrovna-ОвсепянМери РобертовнаOvsepyanMeri Robertovna-БояджянАнна СуреновнаBoyadzhyanAnna Surenovnaaboyajyan@sci.amАракелянАрсен АрташесовичArakelyanArsen Artashesovich-ГеворкянАстхик АртавазовнаGevorkyanAstkhik Artavazdovna-МамиконянАшот АндреевичMamikonyanAshot Andreevich-Институт молекулярной биологии, ЕреванInstitute of Molecular Biology, ErevanМедицинский центр «Армения», ЕреванArmenia Medical Centre, Erevan201115092011143№3 (2011)1720Copyright © Аракелова Э.А., Овсепян М.Р., Бояджян А.С., Аракелян А.А., Геворкян А.А., Мамиконян А.А., 20112011Аракелова Э.А., Овсепян М.Р., Бояджян А.С., Аракелян А.А., Геворкян А.А., Мамиконян А.А.Arakelova E.A., Ovsepyan M.R., Boyadzhyan A.S., Arakelyan A.A., Gevorkyan A.A., Mamikonyan A.A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.dia-endojournals.ru/jour/article/view/6218сахарный диабет 2 типамембраноатакующий комплекссистема комплементаtype 2 diabetes mellitusmembrane attack complexcomplement systemReferencesVolankis J.E., Frank M.M. The human complement system in health and disease // Mircel Dekker. - Inc, New York, 1998.Volankis J.E., Frank M.M. The human complement system in health and disease // Mircel Dekker. - Inc, New York, 1998.Sakamoto M., Fujisawa Y., Nishioka K. Physiologic role of the complement system in host defense, disease, and malnutrition // Nutrition. - 1998. - V. 14 (4). - P. 391-398.Sakamoto M., Fujisawa Y., Nishioka K. Physiologic role of the complement system in host defense, disease, and malnutrition // Nutrition. - 1998. - V. 14 (4). - P. 391-398.Sim R.B., Laich A. Serine proteases of the complement system // BiochemSoc. Trans. - 2000. - V. 28 (5). - P. 545-550.Sim R.B., Laich A. Serine proteases of the complement system // BiochemSoc. Trans. - 2000. - V. 28 (5). - P. 545-550.Mollnes T.E., Song W.C., Lambris J.D. Complement in inflammatory tissue damage and disease // Trends Immunol. Today. - 2002. - V. 23 (2). - P. 61-66.Mollnes T.E., Song W.C., Lambris J.D. Complement in inflammatory tissue damage and disease // Trends Immunol. Today. - 2002. - V. 23 (2). - P. 61-66.Cole D.S., Morgan B.P. Beyond lysis: how complement influences cell fate // Clin. Sci. - 2003. - V.104 (5). - P. 455-466.Cole D.S., Morgan B.P. Beyond lysis: how complement influences cell fate // Clin. Sci. - 2003. - V.104 (5). - P. 455-466.Nauta A.J., Roos A., Daha M.R. A regulatory role for complement in innate immunity and autoimmunity // Int. Arch. Allergy Immunol. - 2004. - V. 134 (4). - P. 310-323.Nauta A.J., Roos A., Daha M.R. A regulatory role for complement in innate immunity and autoimmunity // Int. Arch. Allergy Immunol. - 2004. - V. 134 (4). - P. 310-323.Handwerger B.S., Fernandes G., Brown D.M. Immune and autoimmune aspects of diabetes mellitus // Hum. Pathol. - 1980. - V. 11 (4). - P. 338-352.Handwerger B.S., Fernandes G., Brown D.M. Immune and autoimmune aspects of diabetes mellitus // Hum. Pathol. - 1980. - V. 11 (4). - P. 338-352.Pino S.C., Kruger A.J., Bortell R. The role of innate immune pathways in type 1 diabetes pathogenesis // Curr. Opin. Endocrinol. Diabetes Obes. - 2010. - V. 17 (2). - P. 126-130.Pino S.C., Kruger A.J., Bortell R. The role of innate immune pathways in type 1 diabetes pathogenesis // Curr. Opin. Endocrinol. Diabetes Obes. - 2010. - V. 17 (2). - P. 126-130.Donath M.Y., Shoelson S.E. Type 2 diabetes as an inflammatory disease // Nat. Rev. Immunol. - 2011. - V.11 (2). - P. 98-107. 10. Bariş N., Erdoğan M., Sezer E., Saygili F., Mert Ozgönül A., Turgan N.,Donath M.Y., Shoelson S.E. Type 2 diabetes as an inflammatory disease // Nat. Rev. Immunol. - 2011. - V.11 (2). - P. 98-107. 10. Bariş N., Erdoğan M., Sezer E., Saygili F., Mert Ozgönül A., Turgan N.,Ersöz B. Alterations in L-arginine and inflammatory markers in type 2 diabetic patients with and without microalbuminuria // Acta Diabetol. - 2009. - V. 46 (4). - P. 309-316.Ersöz B. Alterations in L-arginine and inflammatory markers in type 2 diabetic patients with and without microalbuminuria // Acta Diabetol. - 2009. - V. 46 (4). - P. 309-316.Huysman E., Mathieu C. Diabetes and peripheral vascular disease // Acta Chir. Belg. - 2009. - V. 109 (5). - P. 587-594.Huysman E., Mathieu C. Diabetes and peripheral vascular disease // Acta Chir. Belg. - 2009. - V. 109 (5). - P. 587-594.Kaneto H., Matsuoka T.A., Nakatani Y., Kawamori D., Miyatsuka T., Matsuhisa M., Yamasaki Y. Oxidative stress, ER stress, and the JNK pathway in type 2 diabetes // J. Mol. Med. - 2005. - V.83 (6). - P. 429-439.Kaneto H., Matsuoka T.A., Nakatani Y., Kawamori D., Miyatsuka T., Matsuhisa M., Yamasaki Y. Oxidative stress, ER stress, and the JNK pathway in type 2 diabetes // J. Mol. Med. - 2005. - V.83 (6). - P. 429-439.Solinas G., Vilcu C., Neels J.G., Bandyopadhyay G.K., Luo J.L., Naugler W., Grivennikov S., Wynshaw-Boris A., Scadeng M., Olefsky J.M., Karin M. JNK1 in hematopoietically derived cells contributes to dietinduced inflammation and insulin resistance without affecting obesity // Cell Metab. - 2007. - V. 6 (5). - P. 386-397.Solinas G., Vilcu C., Neels J.G., Bandyopadhyay G.K., Luo J.L., Naugler W., Grivennikov S., Wynshaw-Boris A., Scadeng M., Olefsky J.M., Karin M. JNK1 in hematopoietically derived cells contributes to dietinduced inflammation and insulin resistance without affecting obesity // Cell Metab. - 2007. - V. 6 (5). - P. 386-397.Овсепян М.Р., Бояджян А.С., Оганесян Л.П., Maмиконян A.A., Геворкян A.A. Активация системы комплемента по классическому и альтернативному пути при длительном течении сахарного диабета 2-готипа // Проблемы эндокринологии (Москва). - 2006 (6). - С. 14-17.Овсепян М.Р., Бояджян А.С., Оганесян Л.П., Maмиконян A.A., Геворкян A.A. Активация системы комплемента по классическому и альтернативному пути при длительном течении сахарного диабета 2-готипа // Проблемы эндокринологии (Москва). - 2006 (6). - С. 14-17.Morgan B.P., Daniels R.H., Williams B.D. Measurement of terminal complement complexes in rheumatoid arthritis // Clin. Exp. Immunol. - 1988. - V. 73. - P. 473-478.Morgan B.P., Daniels R.H., Williams B.D. Measurement of terminal complement complexes in rheumatoid arthritis // Clin. Exp. Immunol. - 1988. - V. 73. - P. 473-478.Watford W.T., Ghio A.J., Wright J.R. Complement-mediated host defense in the lung // Physiol. Lung Cell. Mol. Physiol. - 2000. - V. 279 (5). - P. 790-798.Watford W.T., Ghio A.J., Wright J.R. Complement-mediated host defense in the lung // Physiol. Lung Cell. Mol. Physiol. - 2000. - V. 279 (5). - P. 790-798.Daha M.R. Purification of complement component / In Doods, A.W. and Sim, R.B. eds: Complement. A practical approach. Oxford University press, Oxford. - 1997. - P. 121-133.Daha M.R. Purification of complement component / In Doods, A.W. and Sim, R.B. eds: Complement. A practical approach. Oxford University press, Oxford. - 1997. - P. 121-133.Morgan B.P. Measurement of complement hemolytic activity, generation of complement-depleted sera, and production of hemolytic intermediates / In: Morgan, B.P. ed. Methods in molecular biology. Complement methods and protocols. Humana Press, Totowa, New Jersey. - 2000. - V. 150. - P. 61-71.Morgan B.P. Measurement of complement hemolytic activity, generation of complement-depleted sera, and production of hemolytic intermediates / In: Morgan, B.P. ed. Methods in molecular biology. Complement methods and protocols. Humana Press, Totowa, New Jersey. - 2000. - V. 150. - P. 61-71.Rosoklija G.B., Dwork A.J., Younger D.S., Karlikaya G., Latov N., Hays A.P. Local activation of the complement system in endoneurial microvessels of diabetic neuropathy // Acta Neuropathol. - 2000. - V. 99 (1). - P. 55-62.Rosoklija G.B., Dwork A.J., Younger D.S., Karlikaya G., Latov N., Hays A.P. Local activation of the complement system in endoneurial microvessels of diabetic neuropathy // Acta Neuropathol. - 2000. - V. 99 (1). - P. 55-62.Gerl V.B., Bohl J., Pitz S., Stoffelns B., Pfeiffer N., Bhakdi S. Extensive deposits of complement C3d and C5b-9 in the choriocapillaris of eyes of patients with diabetic retinopathy // Invest Ophthalmol Vis Sci. - 2002. - V.43 (4). - P. 1104-1108.Gerl V.B., Bohl J., Pitz S., Stoffelns B., Pfeiffer N., Bhakdi S. Extensive deposits of complement C3d and C5b-9 in the choriocapillaris of eyes of patients with diabetic retinopathy // Invest Ophthalmol Vis Sci. - 2002. - V.43 (4). - P. 1104-1108.Галстян Г.Р. Метаболические нарушения при сахарном диабете 2 типа и методы их коррекции // Русский медицинский журнал. - 2001. - Т. 9 (24). - С. 1098-1100.Галстян Г.Р. Метаболические нарушения при сахарном диабете 2 типа и методы их коррекции // Русский медицинский журнал. - 2001. - Т. 9 (24). - С. 1098-1100.DeFronzo R.A. Pathogenesis of type 2 diabetes mellitus // Med. Clin. N. Am. - 2004. - V. 88. - P. 787-835.DeFronzo R.A. Pathogenesis of type 2 diabetes mellitus // Med. Clin. N. Am. - 2004. - V. 88. - P. 787-835.Ahlqvist E., Ahluwalia T.S., Groop L. Genetics of type 2 diabetes // Clin. Chem. - 2011. - V. 57 (2). - P. 241-254.Ahlqvist E., Ahluwalia T.S., Groop L. Genetics of type 2 diabetes // Clin. Chem. - 2011. - V. 57 (2). - P. 241-254.McMillan D.E. Development of vascular complications in diabetes // Vasc. Med. - 1997. - V. 2 (2). - P. 132-142.McMillan D.E. Development of vascular complications in diabetes // Vasc. Med. - 1997. - V. 2 (2). - P. 132-142.UKPDS Group. Intensive blood glucose control with sulphonylureasor insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes // Lancet. - 1998. - V. 352. - P. 837-853.UKPDS Group. Intensive blood glucose control with sulphonylureasor insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes // Lancet. - 1998. - V. 352. - P. 837-853.Acosta J., Qin X., Halperin J. Complement and complement regulatory proteins as potential molecular targets for vascular diseases // Curr. Pharm. - 2004. - V. 10 (2). - P. 203-211.Acosta J., Qin X., Halperin J. Complement and complement regulatory proteins as potential molecular targets for vascular diseases // Curr. Pharm. - 2004. - V. 10 (2). - P. 203-211.Huang Y., Smith C.A., Song H., Morgan B.P., Abagyan R. Tomlinson S. Insights into the human CD59 complement binding interface toward engineering new therapeutics // J. Biol. Chem. - 2005. - V. 280 (40). - P. 34073-34079.Huang Y., Smith C.A., Song H., Morgan B.P., Abagyan R. Tomlinson S. Insights into the human CD59 complement binding interface toward engineering new therapeutics // J. Biol. Chem. - 2005. - V. 280 (40). - P. 34073-34079.Acosta J., Hettinga J., Fluckiger R., Krumrei N., Goldfine A., Angarita L., Halperin J. Molecular basis for a link between complement and the vascular complications of diabetes // Proc. Natl. Acad. Sci. USA. - 2000. - V. 97 (10). - 5450-5455.Acosta J., Hettinga J., Fluckiger R., Krumrei N., Goldfine A., Angarita L., Halperin J. Molecular basis for a link between complement and the vascular complications of diabetes // Proc. Natl. Acad. Sci. USA. - 2000. - V. 97 (10). - 5450-5455.Qin X., Goldfine A., Krumrei N., Grubissich L., Acosta J., Chorev M., Hays A.P., Halperin J.A. Glycation inactivation of the complement regulatory protein CD59. A possible role in the pathogenesis of the vascular complications of human diabetes // Diabetes. - 2004. - V. 53. - P. 2653-2661.Qin X., Goldfine A., Krumrei N., Grubissich L., Acosta J., Chorev M., Hays A.P., Halperin J.A. Glycation inactivation of the complement regulatory protein CD59. A possible role in the pathogenesis of the vascular complications of human diabetes // Diabetes. - 2004. - V. 53. - P. 2653-2661.Cheng Y., Gao M. The effect of glycation of CD59 on complementmediated cytolysis // Cell. Mol. Immunol. - 2005. - V. 2 (4). - P. 313-317.Cheng Y., Gao M. The effect of glycation of CD59 on complementmediated cytolysis // Cell. Mol. Immunol. - 2005. - V. 2 (4). - P. 313-317.Barber A.J., Gardner T.W., Abcouwer S.F. The significance of vascular and neural apoptosis to the pathology of diabetic retinopathy // Invest. Ophthalmol. Vis. Sci. - 2011. - V. 52 (2). - P. 1156-1163.Barber A.J., Gardner T.W., Abcouwer S.F. The significance of vascular and neural apoptosis to the pathology of diabetic retinopathy // Invest. Ophthalmol. Vis. Sci. - 2011. - V. 52 (2). - P. 1156-1163.Park S.H., Park J.W., Park S.J., Kim K.Y., Chung J.W., Chun M.H., Oh S.J. Apoptotic death of photoreceptors in the streptozotocin-induced diabetic rat retina // Diabetologia. - 2003. - V. 46 (9). - P. 1260-1268.Park S.H., Park J.W., Park S.J., Kim K.Y., Chung J.W., Chun M.H., Oh S.J. Apoptotic death of photoreceptors in the streptozotocin-induced diabetic rat retina // Diabetologia. - 2003. - V. 46 (9). - P. 1260-1268.
The authors declare that there are no conflicts of interest present.